Q1 EPS Estimates for Cytosorbents Lowered by Zacks Research

Chronological Source Flow
Back

AI Fusion Summary

Zacks Research lowered Q1 2026 EPS for Cytosorbents to $‑0.06, FY2026 to $‑0.30, and Q3 2026 EPS for EOG Resources to $2.50. Soligenix FY2026 EPS cut to $1.14, with Weiss Ratings maintaining a sell stance.
#ZACKS_RESEARCH #CYTO_SORBET #SOLIGENIX #EOG_RESOURCES #EPS_ESTIMATE #SELL_RATING #US_STOCKS
09/04 08:14 defenseworld.net
3 Πηγές

Q1 EPS Estimates for Cytosorbents Lowered by Zacks Research

CytosorbentsZacks ResearchEPSQ1 2026earnings forecastmedical research
09/04 09:06 defenseworld.net

Soligenix FY2026 EPS Estimate Lowered by Zacks Research

ANALYST ARTICLES - ESTIMATESPOLITICSCOMPANIES
09/04 09:38 defenseworld.net

Q3 EPS Estimates for EOG Resources Reduced by Zacks Research

ANALYST ARTICLES - ESTIMATESPOLITICSCOMPANIES
Comments
Loading...
0